UGOLOTTI, MARTINA
 Distribuzione geografica
Continente #
AS - Asia 83
EU - Europa 44
NA - Nord America 34
SA - Sud America 12
AF - Africa 2
Totale 175
Nazione #
US - Stati Uniti d'America 34
SG - Singapore 32
CN - Cina 25
IT - Italia 24
BR - Brasile 8
VN - Vietnam 8
DE - Germania 7
HK - Hong Kong 7
RU - Federazione Russa 4
GB - Regno Unito 3
IQ - Iraq 3
AR - Argentina 2
IE - Irlanda 2
IN - India 2
KR - Corea 2
KZ - Kazakistan 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
FR - Francia 1
JO - Giordania 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 175
Città #
Singapore 11
Dallas 10
Parma 9
Hefei 8
Hong Kong 7
Ashburn 6
Beijing 5
Ho Chi Minh City 4
Los Angeles 3
Munich 3
Berlin 2
Brooklyn 2
Buffalo 2
Dublin 2
Frankfurt am Main 2
Hanoi 2
Milan 2
Piscataway 2
Seoul 2
Taiyuan 2
Verona 2
Almaty 1
Amman 1
Amsterdam 1
As Samawah 1
Bengaluru 1
Boston 1
Cairo 1
Canoas 1
Curitiba 1
Guangzhou 1
Helena 1
Irecê 1
Jaboticabal 1
Jiaxing 1
Johannesburg 1
Karaganda 1
London 1
Moscow 1
Mosul 1
Mumbai 1
North Bergen 1
Paris 1
Poplar 1
Rosario 1
San Miguel de Tucumán 1
Santa Bárbara do Pará 1
Shanghai 1
São Paulo 1
Sóc Trăng 1
Villarrica 1
Warsaw 1
Totale 119
Nome #
Anti-atherosclerotic effects of natural compounds targeting lipid metabolism and inflammation: Focus on PPARs, LXRs, and PCSK9 91
“Investigating PCSK9 inhibition as potential strategy in Alzheimer’s disease” 19
"Effect of natural and synthetic PCSK9 inhibitors on Alzheimer’s disease-related parameters in human cerebral cell models" 15
Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's Disease 14
In vitro and in vivo studies on novel PCSK9 inhibitors as pharmacological approach for the treatment of Alzheimer’s disease 11
“PCSK9 inhibition as potential strategy to treat Alzheimer’s disease: in vitro and in vivo studies” 11
“Proprotein convertase subtilisin/kexin type 9 and plasma/cerebrospinal fluid lipids in patients with cognitive decline” 10
“Studi in vitro e in vivo per lo sviluppo di nuovi inibitori di PCSK9 come strategia terapeutica nella malattia di Alzheimer” 8
“Probing the efficacy of natural and novel synthetic PCSK9 inhibitors in reducing neuroinlfammation, Aβ-induced neurotoxicity and modulating cholesterol uptake in human cerebral cell models” 7
Totale 186
Categoria #
all - tutte 503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202534 0 0 0 0 0 0 0 0 11 5 2 16
2025/2026152 6 16 17 11 95 7 0 0 0 0 0 0
Totale 186